TrialJournal of immunology research2019

Low-Dose Sirolimus Immunoregulation Therapy in Patients with Active Rheumatoid Arthritis: A 24-Week Follow-Up of the Randomized, Open-Label, Parallel-Controlled Trial.

Hong-Yan Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.